![Katja Buhrer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Katja Buhrer worked as a Managing Director at MBS Value Partners, Inc. from 2011 to 2017.
She then served as the COO & VP-Corporate Development & Investor Relations at Kindred Biosciences, Inc. from 2018 to 2021.
In 2022, she became the Chief Strategy Officer at ObsEva SA. Prior to her professional career, Ms. Buhrer completed her undergraduate degree at The University of New South Wales.
Precedenti posizioni note di Katja Buhrer
| Società | Posizione | Fine |
|---|---|---|
| OBSEVA SA | Contatto Relazioni con gli Investitori | 02/02/2022 |
| KINDRED BIOSCIENCES, INC. | Direttore operativo | 01/12/2021 |
MBS Value Partners, Inc.
 MBS Value Partners, Inc. Investment ManagersFinance Operates as an investor relations and financial communications advisory company | Corporate Officer/Principal | 01/11/2017 |
Formazione di Katja Buhrer
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
32
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Kindred Biosciences, Inc.
 Kindred Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for animals | Health Technology |
The University of New South Wales
 The University of New South Wales Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MBS Value Partners, Inc.
MBS Value Partners, Inc. Investment ManagersFinance Operates as an investor relations and financial communications advisory company | Finance |
ObsEva SA
 ObsEva SA Pharmaceuticals: MajorHealth Technology Provides therapeutic treatments to increase women's reproductivity | Health Technology |
